Sodium Hydrogen Exchanger 7 (SLC9A7) Peptide
SLC9A7
Reactivity: Mammalian
Host: Synthetic
BP, WB, IHC
-
- Target See all NHE7 (SLC9A7) products
- NHE7 (SLC9A7) (Sodium Hydrogen Exchanger 7 (SLC9A7))
- Peptide Type
- Synthetic
- Origin
- Mammalian
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Sequence
- LGWGLRVAAA ASASSSGAAA EDSSAMEELA TEKEAEESHR QDSVSLLTFI
- Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of SLC9 A7 antibody,
Alternative Names: SLC9A7 control peptide, SLC9A7 antibody Blocking Peptide, Anti-SLC9A7 Blocking Peptide, Solute Carrier Family 9 Member 7 Blocking Peptide, Sodium/Hydrogen Exchanger 7 Blocking Peptide, NHE7 Blocking Peptide, SLC9A6 Blocking Peptide, SLC9A7, SLCA7-9, SLCA7 9, SLCA7-9 Blocking Peptide, SLCA7 9 Blocking Peptide
-
-
- Application Notes
- Optimal conditions should be determined by the investigator
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
- Buffer
- PBS
- Handling Advice
- Avoid repeated freeze/thaw cycles.
- Storage
- -20 °C
- Storage Comment
- Store at -20 °C long term.
-
- Target
- NHE7 (SLC9A7) (Sodium Hydrogen Exchanger 7 (SLC9A7))
- Background
- Organelles of the secretory and endocytic pathways are distinguished by their luminal acidity, which is generated by the activity of an electrogenic vacuolar-type hydrogen ATPase. Progressive acidification of vesicles in the endocytic pathway is essential for the redistribution and degradation of internalized membrane proteins, such as ligand receptor complexes and fluid-phase solutes. It may play an important role in maintaining cation homeostasis and function of the trans-Golgi network.
- Molecular Weight
- 80 kDa
-
You are here:
